cometadata/datacite-titles-descriptions-related-identifiers huggingface dataset:
DOI: 10.48597/r4kd-n5va
title: Measurement of Alpha_HCH at Kosetice (NOAK)

description: Measurement of Alpha_HCH at Kosetice (NOAK)
DOI: 10.48597/r7ju-4f9q
title: Measurement of HCB at Kosetice (NOAK)

description: Measurement of HCB at Kosetice (NOAK)
DOI: 10.48597/rbc2-mtme
title: Measurement of Sulphur_dioxide at Churanov

description: Measurement of Sulphur_dioxide at Churanov
DOI: 10.48597/smnj-zstn
title: Measurement of Benzo_ghi_perylene at Kosetice (NOAK)

description: Measurement of Benzo_ghi_perylene at Kosetice (NOAK)
DOI: 10.48597/spdd-hqg4
title: Measurement of Pp_DDE at Kosetice (NOAK)

description: Measurement of Pp_DDE at Kosetice (NOAK)
DOI: 10.48597/t4zx-zwsz
title: Measurement of Benz_a_anthracene at Kosetice (NOAK)

description: Measurement of Benz_a_anthracene at Kosetice (NOAK)
DOI: 10.48597/tdve-55hr
title: Measurement of Anthracene at Kosetice (NOAK)

description: Measurement of Anthracene at Kosetice (NOAK)
DOI: 10.48597/th2h-duye
title: Measurement of Benzo_k_fluoranthene at Kosetice (NOAK)

description: Measurement of Benzo_k_fluoranthene at Kosetice (NOAK)
DOI: 10.48597/u7g4-38bv
title: Measurement of PCB_101 at Kosetice (NOAK)

description: Measurement of PCB_101 at Kosetice (NOAK)
DOI: 10.48597/vsdz-e5ff
title: Measurement of Benzo_a_pyrene at Kosetice (NOAK)

description: Measurement of Benzo_a_pyrene at Kosetice (NOAK)
DOI: 10.48597/vy93-qtvu
title: Measurement of Potassium at Kosetice (NOAK)

description: Measurement of Potassium at Kosetice (NOAK)
DOI: 10.48597/vyrz-stu6
title: Measurement of Inden_123cd_pyrene at Kosetice (NOAK)

description: Measurement of Inden_123cd_pyrene at Kosetice (NOAK)
DOI: 10.48597/wbtf-tccv
title: Measurement of Acenaphthene at Kosetice (NOAK)

description: Measurement of Acenaphthene at Kosetice (NOAK)
DOI: 10.48597/ww4d-2cez
title: Measurement of PCB_153 at Kosetice (NOAK)

description: Measurement of PCB_153 at Kosetice (NOAK)
DOI: 10.6084/m9.figshare.24633306
title: Additional file 1 of Awareness with paralysis and symptoms of post-traumatic stress disorder among mechanically ventilated emergency department survivors (ED-AWARENESS-2 Trial): study protocol for a pragmatic, multicenter, stepped wedge cluster randomized trial

description: Additional file 1.
DOI: 10.6084/m9.figshare.24633306.v1
title: Additional file 1 of Awareness with paralysis and symptoms of post-traumatic stress disorder among mechanically ventilated emergency department survivors (ED-AWARENESS-2 Trial): study protocol for a pragmatic, multicenter, stepped wedge cluster randomized trial

description: Additional file 1.
DOI: 10.6084/m9.figshare.6807518
title: Porous silicon based intravitreal platform for dual-drug loading and controlled release towards synergistic therapy

description: The number of blind and low vision persons in the US is projected to increase to 5.68 million by 2020. The eye diseases causing loss of vision are life-long, chronic, and often need protracted presence of therapeutics at the disease site to keep the disease in remission. In addition, multiple pathologies participate in the disease process and a single therapy seems insufficient to bring the disease under control and prevent vision loss. This study demonstrates the use of porous silicon (pSi) particles sequentially loaded with daunorubicin (DNR) and dexamethasone (DEX) to create a synergistic intravitreally injectable dual-drug delivery system. DEX targets chronic inflammation while DNR inhibits excessive cell proliferation as well as suppresses hypoxia-inducible factor 1 to reduce scarring. This pSi-based delivery system releases therapeutic concentrations of DNR for 100 days and DEX for over 165 days after a single dose. This intravitreal dual-drug delivery system is also well tolerated after injection into the rabbit eye model, attested by ocular biomicroscopy, ocular tonometry, electroretinography, and histology. This novel dual-drug delivery system opens an attractive modality for combination therapy to manage refractory chorioretinal diseases and further preclinical studies are warranted to evaluate its efficacy.
DOI: 10.6084/m9.figshare.6807518.v2
title: Porous silicon based intravitreal platform for dual-drug loading and controlled release towards synergistic therapy

description: The number of blind and low vision persons in the US is projected to increase to 5.68 million by 2020. The eye diseases causing loss of vision are life-long, chronic, and often need protracted presence of therapeutics at the disease site to keep the disease in remission. In addition, multiple pathologies participate in the disease process and a single therapy seems insufficient to bring the disease under control and prevent vision loss. This study demonstrates the use of porous silicon (pSi) particles sequentially loaded with daunorubicin (DNR) and dexamethasone (DEX) to create a synergistic intravitreally injectable dual-drug delivery system. DEX targets chronic inflammation while DNR inhibits excessive cell proliferation as well as suppresses hypoxia-inducible factor 1 to reduce scarring. This pSi-based delivery system releases therapeutic concentrations of DNR for 100 days and DEX for over 165 days after a single dose. This intravitreal dual-drug delivery system is also well tolerated after injection into the rabbit eye model, attested by ocular biomicroscopy, ocular tonometry, electroretinography, and histology. This novel dual-drug delivery system opens an attractive modality for combination therapy to manage refractory chorioretinal diseases and further preclinical studies are warranted to evaluate its efficacy.
DOI: 10.6084/m9.figshare.6807518.v1
title: Porous silicon based intravitreal platform for dual-drug loading and controlled release towards synergistic therapy

description: The number of blind and low vision persons in the US is projected to increase to 5.68 million by 2020. The eye diseases causing loss of vision are life-long, chronic, and often need protracted presence of therapeutics at the disease site to keep the disease in remission. In addition, multiple pathologies participate in the disease process and a single therapy seems insufficient to bring the disease under control and prevent vision loss. This study demonstrates the use of porous silicon (pSi) particles sequentially loaded with daunorubicin (DNR) and dexamethasone (DEX) to create a synergistic intravitreally injectable dual-drug delivery system. DEX targets chronic inflammation while DNR inhibits excessive cell proliferation as well as suppresses hypoxia-inducible factor 1 to reduce scarring. This pSi-based delivery system releases therapeutic concentrations of DNR for 100 days and DEX for over 165 days after a single dose. This intravitreal dual-drug delivery system is also well tolerated after injection into the rabbit eye model, attested by ocular biomicroscopy, ocular tonometry, electroretinography, and histology. This novel dual-drug delivery system opens an attractive modality for combination therapy to manage refractory chorioretinal diseases and further preclinical studies are warranted to evaluate its efficacy.
DOI: 10.4121/7285a143-eeaa-4ee8-91b1-e3ad10ed5b20
title: Data underlying the research of percutaneous microwave ablation of lung lesions

description: 对在南通大学附属医院胸外科接受微波消融术的患者，收集患者的结构化和非结构化数据，进行统计学分析。<br>This dataset comprises patient data collected from individuals undergoing percutaneous microwave ablation of lung lesions at the Department of Thoracic Surgery, Nantong University Affiliated Hospital.- The dataset encompasses both structured and unstructured data, including demographic information, clinical parameters, imaging results, and pathological reports.- Data files are provided in Excel spreadsheet format (*.xlsx).
DOI: 10.4121/7285a143-eeaa-4ee8-91b1-e3ad10ed5b20.v1
title: Data underlying the research of percutaneous microwave ablation of lung lesions

description: 对在南通大学附属医院胸外科接受微波消融术的患者，收集患者的结构化和非结构化数据，进行统计学分析。<br>This dataset comprises patient data collected from individuals undergoing percutaneous microwave ablation of lung lesions at the Department of Thoracic Surgery, Nantong University Affiliated Hospital.- The dataset encompasses both structured and unstructured data, including demographic information, clinical parameters, imaging results, and pathological reports.- Data files are provided in Excel spreadsheet format (*.xlsx).
DOI: 10.48597/xgg3-gmjj
title: Measurement of Pyrene at Kosetice (NOAK)

description: Measurement of Pyrene at Kosetice (NOAK)
DOI: 10.48597/xzx3-8t7h
title: Measurement of Nitrate at Kosetice (NOAK)

description: Measurement of Nitrate at Kosetice (NOAK)
DOI: 10.48597/yfc2-spbh
title: Measurement of Benz_a_anthracene at Kosetice (NOAK)

description: Measurement of Benz_a_anthracene at Kosetice (NOAK)
DOI: 10.48597/yfze-c78c
title: Measurement of Sum_nitric_acid_and_nitrate at Churanov

description: Measurement of Sum_nitric_acid_and_nitrate at Churanov
DOI: 10.48597/zuhv-tcjp
title: Measurement of PCB_180 at Kosetice (NOAK)

description: Measurement of PCB_180 at Kosetice (NOAK)
DOI: 10.48597/29nx-wmn9
title: Measurement of Magnesium at Kosetice (NOAK)

description: Measurement of Magnesium at Kosetice (NOAK)
DOI: 10.48597/2hh7-sgk4
title: Measurement of Cadmium at Svratouch

description: Measurement of Cadmium at Svratouch
DOI: 10.48597/2x98-h98w
title: Measurement of Potassium at Lahemaa

description: Measurement of Potassium at Lahemaa
DOI: 10.48597/3a33-2f28
title: Measurement of Nitrogen_dioxide at Lahemaa

description: Measurement of Nitrogen_dioxide at Lahemaa
DOI: 10.48597/3ggn-pu7x
title: Measurement of Magnesium at Lahemaa

description: Measurement of Magnesium at Lahemaa
DOI: 10.48597/3jun-sxj8
title: Measurement of Nickel at Campisabalos

description: Measurement of Nickel at Campisabalos
DOI: 10.48597/3qjw-qzpf
title: Measurement of Nitrate at Zarra

description: Measurement of Nitrate at Zarra
DOI: 10.48597/3waq-ankm
title: Measurement of Chloride at Lahemaa

description: Measurement of Chloride at Lahemaa
DOI: 10.48597/4aun-uvrj
title: Measurement of Aerosol_absorption_coefficient at Puy de Dôme

description: Measurement of Aerosol_absorption_coefficient at Puy de Dôme
DOI: 10.48597/4nf3-ygb2
title: Measurement of Nitrate at Cabo de Creus

description: Measurement of Nitrate at Cabo de Creus
DOI: 10.48597/4pp5-fj85
title: Measurement of Calcium at Kosetice (NOAK)

description: Measurement of Calcium at Kosetice (NOAK)
DOI: 10.48597/4urx-w9fw
title: Measurement of Arsenic at Víznar

description: Measurement of Arsenic at Víznar
DOI: 10.48597/5aue-4d43
title: Measurement of Aerosol_light_scattering_coefficient at Finokalia

description: Measurement of Aerosol_light_scattering_coefficient at Finokalia
DOI: 10.48597/5nek-2ucr
title: Measurement of Pm10_mass at Lahemaa

description: Measurement of Pm10_mass at Lahemaa
DOI: 10.48597/63d8-2px2
title: Measurement of Pm10_mass at Campisabalos

description: Measurement of Pm10_mass at Campisabalos
DOI: 10.48597/66da-3tyy
title: Measurement of Magnesium at Lahemaa

description: Measurement of Magnesium at Lahemaa
DOI: 10.48597/69e4-bv4a
title: Measurement of Magnesium at Vilsandi

description: Measurement of Magnesium at Vilsandi
DOI: 10.48597/6gmp-99nj
title: Measurement of Pm10_mass at Kosetice (NOAK)

description: Measurement of Pm10_mass at Kosetice (NOAK)
DOI: 10.48597/6hpq-hdys
title: Measurement of Cadmium at Kosetice (NOAK)

description: Measurement of Cadmium at Kosetice (NOAK)
DOI: 10.48597/6pzg-u8tk
title: Measurement of Phenanthrene at Harwell

description: Measurement of Phenanthrene at Harwell
DOI: 10.48597/75qg-9vnv
title: Measurement of Conductivity at Lahemaa

description: Measurement of Conductivity at Lahemaa
DOI: 10.48597/76tw-6rfn
title: Measurement of Calcium at Vilsandi

description: Measurement of Calcium at Vilsandi
DOI: 10.48597/79e4-qctv
title: Measurement of Lead at Víznar

description: Measurement of Lead at Víznar
DOI: 10.48597/7dc7-sbf4
title: Measurement of Benzo_k_fluoranthene at Harwell

description: Measurement of Benzo_k_fluoranthene at Harwell
DOI: 10.48597/7pb6-9aqg
title: Measurement of Calcium at Campisabalos

description: Measurement of Calcium at Campisabalos
DOI: 10.48597/8h2r-hdjv
title: Measurement of Pm10_mass at Churanov

description: Measurement of Pm10_mass at Churanov
DOI: 10.48597/8r6a-946t
title: Measurement of Pm25_mass at Campisabalos

description: Measurement of Pm25_mass at Campisabalos
DOI: 10.48597/8trd-brg7
title: Measurement of Cadmium at Churanov

description: Measurement of Cadmium at Churanov
DOI: 10.48597/8vxu-83fs
title: Measurement of 1-methylnaphthalene at Harwell

description: Measurement of 1-methylnaphthalene at Harwell
DOI: 10.48597/92mb-4ybv
title: Measurement of Elemental_carbon at Campisabalos

description: Measurement of Elemental_carbon at Campisabalos
DOI: 10.48597/9f29-jwbm
title: Measurement of Sulphur_dioxide at Vilsandi

description: Measurement of Sulphur_dioxide at Vilsandi
DOI: 10.48597/ap3h-rva7
title: Measurement of Lead at Churanov

description: Measurement of Lead at Churanov
DOI: 10.48597/azcp-jw3m
title: Measurement of Sulphate_total at Cabo de Creus

description: Measurement of Sulphate_total at Cabo de Creus
DOI: 10.48597/b8ws-6xnf
title: Measurement of 9-methylphenanthrene at Harwell

description: Measurement of 9-methylphenanthrene at Harwell
DOI: 10.48597/bb5x-v7ht
title: Measurement of Pm10_mass at Cabo de Creus

description: Measurement of Pm10_mass at Cabo de Creus
DOI: 10.48597/cq8a-6svj
title: Measurement of Arsenic at Campisabalos

description: Measurement of Arsenic at Campisabalos
DOI: 10.48597/cqdd-6suy
title: Measurement of Sodium at Lahemaa

description: Measurement of Sodium at Lahemaa
DOI: 10.48597/crry-pu89
title: Measurement of Ammonium at Lahemaa

description: Measurement of Ammonium at Lahemaa
DOI: 10.48597/ctf7-j39e
title: Measurement of Sodium at Campisabalos

description: Measurement of Sodium at Campisabalos
DOI: 10.48597/dada-vq7b
title: Measurement of OC/EC at Puy de Dôme

description: Measurement of OC/EC at Puy de Dôme
DOI: 10.48597/deyx-xnur
title: Measurement of Nickel at Churanov

description: Measurement of Nickel at Churanov
DOI: 10.48597/djdu-r2n2
title: Measurement of Dibenzo_ah_pyrene at Harwell

description: Measurement of Dibenzo_ah_pyrene at Harwell
DOI: 10.48597/djpw-cdn7
title: Measurement of Sulphate_total at Barcarrota

description: Measurement of Sulphate_total at Barcarrota
DOI: 10.48597/dtgq-5x76
title: Measurement of Copper at Svratouch

description: Measurement of Copper at Svratouch
DOI: 10.48597/eb8c-kwn8
title: Measurement of Nitrogen_dioxide at Vilsandi

description: Measurement of Nitrogen_dioxide at Vilsandi
DOI: 10.48597/ec9r-2zj6
title: Measurement of Sulphate_total at Vilsandi

description: Measurement of Sulphate_total at Vilsandi
DOI: 10.25345/c5t727s67
title: MassIVE MSV000094229 - DATASET - Top-Down - Snake venom proteomics of seven taxa of the genera Vipera, Montivipera, Macrovipera and Daboia across Turkiye/Turkey
title: This DATASET collection includes the mass spectrometry files for proteomics venom investigation of seven taxa of the genera Vipera, Montivipera, Macrovipera and Daboia across Turkiye/Turkey. Species list: Vipera berus barani Vipera darevskii Montivipera bulgardaghica bulgardaghica Montivipera bulgardaghica albizona Montivipera xanthina Macrovipera lebetinus obtusa Daboia palaestinae Folders - TOP-DOWN PROTEOMICS: The venom pools were investigated by the non-reduced and TCEP reduced top-down (labled as TD) approach and in short: untreated (non-reduced) or TCEP reduced samples submitted to HPLC-MS/MS. Files are included as RAW and MZML format. Used instrument: Q Exactive HF mass spectrometer (Thermo, Bremen, Germany) with a Vanquish ultra-high performance liquid chromatography (UHPLC) system (Agilent Technologies, Waldbronn, Germany) using a reversed-phase Supelco Discovery BIO wide C18 (2.0 x 150 mm; 3 um particle size; 300 A pore size). Modifications: none (either red. or non-red. disulfide bridges)
DOI: 10.48597/ew6b-xb7y
title: Measurement of Sulphate_total at Víznar

description: Measurement of Sulphate_total at Víznar
DOI: 10.48597/ewze-faw8
title: Measurement of Arsenic at Svratouch

description: Measurement of Arsenic at Svratouch
DOI: 10.48597/ff5k-x8gd
title: Measurement of Pm25_mass at Cabo de Creus

description: Measurement of Pm25_mass at Cabo de Creus
DOI: 10.48597/g96z-9zs3
title: Measurement of Zinc at Víznar

description: Measurement of Zinc at Víznar
DOI: 10.48597/gfxv-rkcu
title: Measurement of Arsenic at Churanov

description: Measurement of Arsenic at Churanov
DOI: 10.6084/m9.figshare.23584851
title: The role and clinical significance of microRNA-29a-3p in the development of hypopharyngeal carcinoma

description: Abstract Objective MicroRNA-29a-3p has been reported in a variety of cancers, but its role in hypopharyngeal cancer remains unclear. This study was to determine the role of microRNA-29a-3p in the occurrence and development of hypopharyngeal cancer. Methods 40 patients with hypopharyngeal cancer who underwent surgery in the Affiliated Hospital of Jining Medical University from April 2013 to November 2017 were selected for this study. The cancer tissue samples of the patients were collected, and the patients were followed up for three years. The expression of microRNA-29a-3p in tissue samples was detected by in situ hybridization with fluorescent probe, and the relationships among microRNA-29a-3p and clinicopathological factors, postoperative recurrent-metastasis, survival time were studied. Immunohistochemical was used to detect the expression of Ki67 and E-cadherin in tissue samples. Results Combined with HE staining results showed that microRNA-29a-3p expression was relatively high in non-cancer tissue cells (red blood cells and fibroblasts in tumor interstitial vessels), but was relatively low in cancer tissue and cells. According to the follow-up data of 40 patients with hypopharyngeal cancer, tumor size, T-stage, tumor differentiation, postoperative recurrent-metastasis of hypopharyngeal cancer patients were significantly negatively correlated with microRNA-29a-3p (p&lt; 0.05). Immunohistochemica results further confirmed that microRNA-29a-3p was negatively correlated with the expression of Ki67 and E-cadherin. The survival time of patients positively related with microRNA-29a-3p expression (p&lt; 0.05). Moreover, ROC curve analysis showed that the area under the curve of the combined detection of miRNA-29a-3p+Ki67+E-cadherin was larger than that of the single detection of the three indexes. Conclusions The expression of microRNA-29a-3p is closely related to the occurrence, development and prognosis of hypopharyngeal cancer, and it affects the proliferation and invasion. This indicates that microRNA-29a-3p serves as a therapeutic target for the occurrence and development of hypopharyngeal cancer. The evidence of study designs of this study is IV using “Oxford Centre for Evidence-Based Medicine 2011 Levels of Evidence”.
DOI: 10.48597/gm6z-ewsz
title: Measurement of Calcium at Lahemaa

description: Measurement of Calcium at Lahemaa
DOI: 10.48597/h5ep-rsxy
title: Measurement of Nickel at Víznar

description: Measurement of Nickel at Víznar
DOI: 10.48597/h878-5han
title: Measurement of Organic_carbon at Campisabalos

description: Measurement of Organic_carbon at Campisabalos
DOI: 10.6084/m9.figshare.23584851.v1
title: The role and clinical significance of microRNA-29a-3p in the development of hypopharyngeal carcinoma

description: Abstract Objective MicroRNA-29a-3p has been reported in a variety of cancers, but its role in hypopharyngeal cancer remains unclear. This study was to determine the role of microRNA-29a-3p in the occurrence and development of hypopharyngeal cancer. Methods 40 patients with hypopharyngeal cancer who underwent surgery in the Affiliated Hospital of Jining Medical University from April 2013 to November 2017 were selected for this study. The cancer tissue samples of the patients were collected, and the patients were followed up for three years. The expression of microRNA-29a-3p in tissue samples was detected by in situ hybridization with fluorescent probe, and the relationships among microRNA-29a-3p and clinicopathological factors, postoperative recurrent-metastasis, survival time were studied. Immunohistochemical was used to detect the expression of Ki67 and E-cadherin in tissue samples. Results Combined with HE staining results showed that microRNA-29a-3p expression was relatively high in non-cancer tissue cells (red blood cells and fibroblasts in tumor interstitial vessels), but was relatively low in cancer tissue and cells. According to the follow-up data of 40 patients with hypopharyngeal cancer, tumor size, T-stage, tumor differentiation, postoperative recurrent-metastasis of hypopharyngeal cancer patients were significantly negatively correlated with microRNA-29a-3p (p&lt; 0.05). Immunohistochemica results further confirmed that microRNA-29a-3p was negatively correlated with the expression of Ki67 and E-cadherin. The survival time of patients positively related with microRNA-29a-3p expression (p&lt; 0.05). Moreover, ROC curve analysis showed that the area under the curve of the combined detection of miRNA-29a-3p+Ki67+E-cadherin was larger than that of the single detection of the three indexes. Conclusions The expression of microRNA-29a-3p is closely related to the occurrence, development and prognosis of hypopharyngeal cancer, and it affects the proliferation and invasion. This indicates that microRNA-29a-3p serves as a therapeutic target for the occurrence and development of hypopharyngeal cancer. The evidence of study designs of this study is IV using “Oxford Centre for Evidence-Based Medicine 2011 Levels of Evidence”.
DOI: 10.48597/hafu-dga4
title: Measurement of Potassium at Campisabalos

description: Measurement of Potassium at Campisabalos
DOI: 10.48597/hzqv-adeb
title: Measurement of Nitrate at Campisabalos

description: Measurement of Nitrate at Campisabalos
DOI: 10.48597/jq7a-g437
title: Measurement of Pm10_mass at Svratouch

description: Measurement of Pm10_mass at Svratouch
DOI: 10.48597/jvhu-rwhs
title: Measurement of Ammonium at Vilsandi

description: Measurement of Ammonium at Vilsandi
DOI: 10.48597/jw77-kbjr
title: Measurement of Copper at Kosetice (NOAK)

description: Measurement of Copper at Kosetice (NOAK)
DOI: 10.48597/jytz-4y3x
title: Measurement of Calcium at Lahemaa

description: Measurement of Calcium at Lahemaa
DOI: 10.48597/k7rq-cjzn
title: Measurement of Nitrate at Lahemaa

description: Measurement of Nitrate at Lahemaa
DOI: 10.48597/kbcw-dp9w
title: Measurement of Sodium at Lahemaa

description: Measurement of Sodium at Lahemaa
DOI: 10.48597/m6u4-9gcw
title: Measurement of Sodium at Víznar

description: Measurement of Sodium at Víznar
DOI: 10.48597/mf4t-eewp
title: Measurement of Nickel at Svratouch

description: Measurement of Nickel at Svratouch
DOI: 10.48597/ne3m-54d8
title: Measurement of Arsenic at Kosetice (NOAK)

description: Measurement of Arsenic at Kosetice (NOAK)
DOI: 10.48597/nesr-7s67
title: Measurement of Manganese at Kosetice (NOAK)

description: Measurement of Manganese at Kosetice (NOAK)
DOI: 10.48597/nq56-dzq4
title: Measurement of Manganese at Svratouch

description: Measurement of Manganese at Svratouch
DOI: 10.48597/pkzu-3nud
title: Measurement of Manganese at Churanov

description: Measurement of Manganese at Churanov
DOI: 10.48597/pqtj-avrh
title: Measurement of Aerosol_absorption_coefficient at Puy de Dôme

description: Measurement of Aerosol_absorption_coefficient at Puy de Dôme
DOI: 10.48597/pxgq-5xzn
title: Measurement of Sulphate_total at Lahemaa

description: Measurement of Sulphate_total at Lahemaa
DOI: 10.48597/q2nb-emv6
title: Measurement of Sodium at Kosetice (NOAK)

description: Measurement of Sodium at Kosetice (NOAK)
DOI: 10.48597/qunr-zj3e
title: Measurement of Copper at Churanov

description: Measurement of Copper at Churanov
DOI: 10.48597/r4pj-exqw
title: Measurement of Cadmium at Campisabalos

description: Measurement of Cadmium at Campisabalos
DOI: 10.48597/r4xq-h47q
title: Measurement of Chromium at Víznar

description: Measurement of Chromium at Víznar
DOI: 10.48597/rfry-y34m
title: Measurement of VOC (hydrocarbons) at Rigi

description: Measurement of VOC (hydrocarbons) at Rigi